Abstract
Recent studies in our laboratory reported frequent loss of heterozygosity (LOH) on mouse chromosome 4 in T-cell lymphomas, identifying three candidate tumor suppressor regions (TLSR1 – 3). To determine the possible existence of other tumor suppressor gene loci on the proximal-mid part of chromosome 4 and to clarify whether the p16INK4a (α and β) and p15INK4b genes are the inactivation targets of deletion at TLSR1, we have tested 73 γ-radiation-induced T-cell lymphomas of F1 hybrid mice by LOH analysis. Frequent LOH was found at the INK4a and INK4b loci and the surrounding markers D4Mit77, D4Mit245 and D4Wsm1. In addition, we identified two distinct regions of significant allelic losses in the proximal-mid part of chromosome 4, defined by the markers D4Mit116 (TLSR4) and D4Mit21 (TLSR5). Taken together, this evidence and our previous data indicate the existence of at least five different candidate sites for tumor suppressor genes on chromosome 4, thus revealing a main role for this chromosome in the development of mouse T-cell lymphomas.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Aldaz CM, Liao QY, Paladugu A, Rehm S and Wang H. . 1996 Mol. Carcinog. 17: 126–133.
Bell DW, Jhanwar SC and Testa JR. . 1997 Cancer Res. 57: 4057–4062.
Cairns P, Okami K, King P, Bonacum J, Ahrendt S, Wu L, Mao L, Jen J and Sidransky D. . 1997 Cancer Res. 57: 5356–5359.
Cayuela JM, Gardie B and Sigaux F. . 1997 Blood 90: 3720–3726.
Farrell WE, Simpson DJ, Bicknell JE, Talbot AJ, Bates AS and Clayton RN. . 1997 Cancer Res. 57: 2703–2709.
Gardie B, Cayuela JM, Martini S and Sigaux F. . 1998 Blood 91: 1016–1020.
Gupta PK, Sahota A, Boyadjiev SA, Bye S, Shao C, O'Neill P, Humter TC, Albertini RJ, Stambrook PJ and Tischfield JA. . 1997 Cancer Res. 57: 1188–1193.
Hegi ME, Devereux TR, Dietrich WF, Cochran CJ, Lander ES, Foley JF, Maronpot RR, Anderson MW and Wiseman RW. . 1994 Cancer Res. 54: 6257–6264.
Herman JG, Jen J, Merlo A and Baylin SB. . 1996 Cancer Res. 56: 722–726.
Herzog CR and You M. . 1997 Mamm. Genome 8: 65–66.
Herzog CR, Wiseman RW and You M. . 1994 Cancer Res. 54: 4007–4010.
Herzog CR, Wang Y and You M. . 1995 Oncogene 11: 1811–1815.
Herzog CR, Soloff EV, McDoniels AL, Tyson FL, Malkinson AM, Haugen-Strano A, Wiseman RW, Anderson MW and You M. . 1996 Oncogene 13: 1885–1891.
Hannon GJ and Beach D. . 1994 Nature 371: 257–261.
Holland EA, Beaton SC, Edwards BG, Kefford RF and Mann GJ. . 1994 Oncogene 9: 1361–1365.
Holmberg E, Rozell BL and Toftgard R. . 1996 Br. J. Cancer 74: 246–250.
Johnson DW, Qumsiyeh M, Benkhalifa M and Marchuk DA. . 1995 Genomics 28: 356–357.
Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavitgian SV, Stockert E, Day III RS, Johnson BE and Skolnick MH. . 1994 Science 264: 436–440.
Kim SK, Ro JY, Kemp BL, Lee JS, Kwon TJ, Fong KM, Sekido Y, Minna JD, Hong WK and Mao L. . 1997 Cancer Res. 57: 400–403.
Kuan J and Kono DH. . 1998 Mamm. Genome 9: 95–96.
Lee GH, Ogawa K, Nishimori H and Drinkwater NR. . 1995 Oncogene 11: 2281–2287.
Malumbres M, Pérez de Castro I, Santos J, Meléndez B, Mangues R, Serrano M, Pellicer A and Fernández-Piqueras J. . 1997 Oncogene 14: 1361–1370.
Malumbres M, Pérez de Castro I, Santos J, Pérez-Ollé R, Fernández-Piqueras J and Pellicer A. . 1998a Mamm. Genome 9: 183–185.
Malumbres M, Pérez de Castro I, Santos J, Fernández-Piqueras J and Pellicer A. . 1998b Oncogene 18: 385–396.
Miura K, Okita K, Furukawa Y, Matsuno S and Nakamura Y. . 1995 Cancer Res. 55: 1828–1830.
Miyasaka K, Ohtake K, Nomura K, Kanda H, Kominami R, Miyashita R and Kitagawa T. . 1995 Mol. Carcinog. 13: 37–43.
Mock BA and Hirano MC. . 1998 Mamm. Genome 8: S68–S90.
Neville EM, Stewart M, Myskow M, Donnelly RJ and Field JK. . 1995 Oncogene 11: 581–585.
Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K and Carson DA. . 1994 Nature 368: 753–756.
Pasche B, Luo Y, Rao PH, Nimer SD, Dimitrovsky E, Caron P, Luzzatto L, Offit K, Cordón-cardo C, Renault B, Satagopan JM, Murty VVVS and Massague J. . 1998 Cancer Res. 58: 2727–2732.
Quelle DE, Ahsmun RA, Hannon GJ, Rehberger PA, Trono D, Richter KH, Walker C, Beach D, Sherr CJ and Serrano M. . 1995 Oncogene 11: 635–645.
Radany EH, Hong K, Kesharvarzi S, Lander ES and Bishop MJ. . 1997 Proc. Natl. Acad. Sci. USA 94: 8664–8669.
Richards FM, Goudie DR, Cooper WN, Jene Q, Barroso Y, Wicking C, Wainwright BJ and Ferguson-Smith MA. . 1997 Hum. Genet. 101: 317–320.
Ritland SR, Rowse GJ, Chang Y and Gendler SJ. . 1997 Cancer Res. 57: 3520–3525.
Santos J, Pérez de Castro I, Herranz M and Fernández-Piqueras J. . 1995 Cytogenet. Cell Genet. 71: 223–224.
Santos J, Pérez de Castro I, Herranz M, Pellicer A and Fernández-Piqueras J. . 1996 Oncogene 12: 669–676.
Santos J, Herranz M, Pérez de Castro I, Pellicer A and Fernández-Piqueras J. . 1998 Oncogene 17: 925–929.
Schultz DC, Vanderveer L, Buetow KH, Boente MP, Ozols RF, Hamilton TC and Godwin AK. . 1995 Cancer Res. 55: 2150–2157.
Shanley SM, Dawkins H, Wainwright BJ, Wicking C, Heenan P, Eldon M, Searle J and Chevenix-Trench G. . 1995 Hum. Mol. Genet. 4: 129–133.
Simoneau AR, Spruck III, Gonzalez-Zulueta M, Gonzalgo MI, Chang MF, Tsai YC, Dean M, Steven K, Horn T and Jones PA. . 1996 Cancer Res. 56: 5039–5043.
Simoneau M, Aboulkassim TO, LaRue H, Rousseau F and Fradet Y. . 1999 Oncogene 18: 157.
Takita J, Hayashi Y, Kohno T, Yamaguchi N, Hanada R and Yamamoto K. . 1997 Cancer Res. 57: 907–912.
Waber P, Dlugosz S, Cheng QC, Truelson J and Nisen PD. . 1997 Oncogene 15: 1699–1704.
Zhang S, Ramsay ES and Mock B. . 1998 Proc. Natl. Acad. Sci. USA 95: 2429–2434.
Zhuang SM, Eklund LK, Cochran C, Rao GN, Wiseman RW and Söderkvist P. . 1996 Cancer Res. 56: 3338–3343.
Acknowledgements
This work was supported by grants from the Ministerio de Educación y Ciencia of Spain (PM96/001), the Fundación Ramón Areces and the Comunidad Autónoma de Madrid (08.1/0009/1997). We thank Michel Herranz for his technical support.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Meléndez, B., Santos, J. & Fernández-Piqueras, J. Loss of heterozygosity at the proximal-mid part of mouse chromosome 4 defines two novel tumor suppressor gene loci in T-cell lymphomas. Oncogene 18, 4166–4169 (1999). https://doi.org/10.1038/sj.onc.1202826
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1202826
Keywords
This article is cited by
-
Functional Fas (Cd95/Apo-1) promoter polymorphisms in inbred mouse strains exhibiting different susceptibility to γ-radiation-induced thymic lymphoma
Oncogene (2006)
-
Lack of correlation between DNA copy number and mRNA expression levels ofc-myc in γ-radiation-induced mouse thymic lymphomas by using quantitative real-time PCR
Clinical and Translational Oncology (2006)
-
Evidence for a new tumour suppressor gene locus for γ-radiation-induced thymic lymphoma located on the proximal part of mouse chromosome 18
Clinical and Translational Oncology (2004)
-
Evidence of a possible epigenetic inactivation mechanism operating on a region of mouse chromosome 19 in γ-radiation-induced thymic lymphomas
Oncogene (2001)